Company: KAVL
Filing Date: 2025-08-18
Form Type: 424B5
Source: 0001731122-25-001141
Chunk: 60

Company: Kaival Brands Innovations Group, Inc.
Filing Date: 2025-08-18
Form: 424B5
Chunk 60
---
 fewer than all of the warrants represented by such certificates are exercised, a
new certificate will be issued for the remaining amount of warrants.

If mentioned in the prospectus supplement, securities
may be surrendered as all or part of the exercise price for warrants.

Antidilution Provisions

Unless otherwise provided in the applicable prospectus
supplement, the following provisions will apply to any warrants we issue pursuant to this prospectus. In the case of warrants to purchase
common stock, the exercise price payable and the number of shares of common stock purchasable upon warrant exercise may be adjusted in
certain events, including:

<div align='center'>19</div>

| ● | the issuance of a stock dividend to common stockholders or a combination, subdivision or reclassification of common stock; |

| ● | the issuance of rights, warrants or options to all common and preferred stockholders entitling them to purchase common stock for an aggregate consideration per share less than the current market price per share of common stock; |

| ● | any distribution to our common stockholders of evidences of our indebtedness of assets, excluding cash dividends or distributions referred to above; and |

| ● | any other events mentioned in the prospectus supplement. |

The prospectus supplement will describe which, if
any, of these provisions shall apply to a particular series of warrants.

Unless otherwise specified in the applicable prospectus
supplement, no adjustment in the number of shares purchasable upon warrant exercise will be required until cumulative adjustments require
an adjustment of at least 1% of such number and no fractional shares will be issued upon warrant exercise, but we will pay the cash value
of any fractional shares otherwise issuable.

Modification

Unless otherwise provided in the applicable prospectus
supplement, the following provisions will apply to any warrants we issue pursuant to this prospectus. We and any agent for any series
of warrants may amend any warrant or rights agreement and the terms of the related warrants by executing a supplemental agreement, without
any such warrant holders’ consent, for the purpose of:

| ● | curing any ambiguity, any defective or inconsistent provision contained in the agreement, or making any other corrections to the agreement that are not inconsistent with the provisions of the warrant certificates; |

| ● | evidencing the succession of another corporation to us and its assumption of our covenants contained in the agreement and the securities; |

| ● | appointing a successor depository if the securities are issued in the form of global securities; |

| ● |